Grant: Fellowship: Bisby (Prize)
University of Toronto
$5,000.00
Impact of Crohns disease-associated variants of Nod2 on cell function: role in intestinal homeostasis
FY 2010-11
Summary
Almost ten years ago, the Nod2 gene was found to be involved in Crohn's disease risk. Since then, the number of known genes involved in Crohn's disease has risen to eighty, including many genes that may
play a role in the formation of scar tissue (strictures) or cancer, such as TGFb. Although we know that Nod2 is involved in the detection of bacterial breakdown products, many questions remain unanswered
with regards to how Nod2 interacts with other inherited (genes like TGFb) and environmental triggers of Crohn's disease.
The current thinking is that bacteria (and their detection by our immune system) are important in the onset of inflammatory diseases of the bowel. The first line of defence is made up by a single layer of
cells called intestinal epithelial cells (IECs). These cells then inform other immune cells of the intestine of what they are exposed to and whether this poses a threat. One type of immune cells which are
important in keeping the inflammation in the gut under control are called Dendritic Cells (DCs). We aim to study the role of inherited Nod2 alterations in various models of intestinal inflammation,
focusing on the interaction between IECs and DCs and how important TGFb is in this whole process.
We will use stable cell lines, mouse models with known changes to their Nod2 gene as well as a brand new technique (not currently available in Canada) where we can grow small pieces, called organoids,
of intestine from mice. Once we have this technique established in our laboratory, we also plan to grow these organoids from biopsies from patients affected by IBD and healthy controls undergoing a
colonoscopy. Ultimately, this technique would allow us to study a patient's response to infection or other environmental triggers (e.g. drugs used to treat IBD), outside the body without any risk of
exposure for the individual giving a sample. Specifically in this proposal, we plan to focus on the study of the immune system of the gut in these organoids.
Department
Program
Fellowship: Bisby (Prize)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
229949
Name
Van Limbergen Johan E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Impact of Crohns disease-associated variants of Nod2 on cell function: role in intestinal homeostasis
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Fellowship: Bisby (Prize)
Keyworddelim
Adult Intestinal Epithelial Stem Cell; Crohn'S Disease; Inflammatory Bowel Disease; Innate Immunity; Intestinal Epithelial Cell; Long-Lived Intestinal Organoid; Nod2
Abstract
Almost ten years ago, the Nod2 gene was found to be involved in Crohn's disease risk. Since then, the number of known genes involved in Crohn's disease has risen to eighty, including many genes that may
play a role in the formation of scar tissue (strictures) or cancer, such as TGFb. Although we know that Nod2 is involved in the detection of bacterial breakdown products, many questions remain unanswered
with regards to how Nod2 interacts with other inherited (genes like TGFb) and environmental triggers of Crohn's disease.
The current thinking is that bacteria (and their detection by our immune system) are important in the onset of inflammatory diseases of the bowel. The first line of defence is made up by a single layer of
cells called intestinal epithelial cells (IECs). These cells then inform other immune cells of the intestine of what they are exposed to and whether this poses a threat. One type of immune cells which are
important in keeping the inflammation in the gut under control are called Dendritic Cells (DCs). We aim to study the role of inherited Nod2 alterations in various models of intestinal inflammation,
focusing on the interaction between IECs and DCs and how important TGFb is in this whole process.
We will use stable cell lines, mouse models with known changes to their Nod2 gene as well as a brand new technique (not currently available in Canada) where we can grow small pieces, called organoids,
of intestine from mice. Once we have this technique established in our laboratory, we also plan to grow these organoids from biopsies from patients affected by IBD and healthy controls undergoing a
colonoscopy. Ultimately, this technique would allow us to study a patient's response to infection or other environmental triggers (e.g. drugs used to treat IBD), outside the body without any risk of
exposure for the individual giving a sample. Specifically in this proposal, we plan to focus on the study of the immune system of the gut in these organoids.
Competitiondate
201010
Approvedterm2
1 yr 0 mth
Pinamesdelim
Van Limbergen, Johan E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $5,000~ $0~